The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Salamol CFC-Free Inhaler 100 micrograms Pressurised Inhalation, Suspension

100 microgram(s) Pressurised inhalation, suspension

Imbat LimitedPPA1151/074/001

Main Information

Trade NameSalamol CFC-Free Inhaler 100 micrograms Pressurised Inhalation, Suspension
Active SubstancesSalbutamol
Strength100 microgram(s)
Dosage FormPressurised inhalation, suspension
Licence HolderImbat Limited
Licence NumberPPA1151/074/001

Group Information

ATC CodeR03AC Selective beta-2-adrenoreceptor agonists
R03AC02 salbutamol


Licence Issued20/06/2008
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceThe authorisation permits the holder to parallel-distribute product marketed in Ireland under the product authorisation number PA0436/032/001 only.
Marketing StatusUnknown


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0078-138-053
Interchangeable List DocumentPDF of Interchangeable List
« Back